![Inklen Serum is an exclusive combination of 2 complementary active substances: - Rucinol, a reference depigmenting activ… | Serum, Cellular level, Shampoo bottle Inklen Serum is an exclusive combination of 2 complementary active substances: - Rucinol, a reference depigmenting activ… | Serum, Cellular level, Shampoo bottle](https://i.pinimg.com/736x/88/46/c8/8846c8796c19db48be99d551ba45ed65.jpg)
Inklen Serum is an exclusive combination of 2 complementary active substances: - Rucinol, a reference depigmenting activ… | Serum, Cellular level, Shampoo bottle
![Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial - Khemis - 2007 - British Journal of Dermatology - Wiley Online Library Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial - Khemis - 2007 - British Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5012aae0-5c7d-40a7-9ad7-f718a897a001/bjd_7814_f2.gif)
Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial - Khemis - 2007 - British Journal of Dermatology - Wiley Online Library
![Figure 4 from The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial. | Semantic Scholar Figure 4 from The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/26ff3328a5f5a08721c00a11078494ba4ebce7c1/4-Figure4-1.png)
Figure 4 from The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial. | Semantic Scholar
![Figure 2 from The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial. | Semantic Scholar Figure 2 from The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/26ff3328a5f5a08721c00a11078494ba4ebce7c1/3-Figure2-1.png)
Figure 2 from The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial. | Semantic Scholar
![Amazon.com: Noreva Iklen+ (Plus) Rucinol Anti-Brown Spot Serum 30ml * NEW Improved Formula : 美容與個人護理 Amazon.com: Noreva Iklen+ (Plus) Rucinol Anti-Brown Spot Serum 30ml * NEW Improved Formula : 美容與個人護理](https://m.media-amazon.com/images/W/MEDIAX_792452-T2/images/I/419MsG9515L._AC_UF1000,1000_QL80_.jpg)